Avego Bioscience Capital | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,145 results for “Avego Bioscience Capital”

TRexBio Secures $84 Million in Series B Funding to Advance TNFR2 Agonist TRB-061

Alveus Therapeutics Raises $160 Million Series A to Advance Novel Obesity Therapies

EpiBiologics Raises $107M Series B to Advance Novel EGFR-Targeting Bispecific Antibody EPI-326 into Clinical Trials

Alveus Therapeutics Emerges with $160M to Develop Next-Generation Obesity Therapies

CellCentric Secures $120 Million Series C Funding to Advance Oral Multiple Myeloma Treatment

myTomorrows Secures $29 Million to Expand AI-Powered Platform for Pre-Approval Treatment Access

IGM Biosciences Downgraded by BMO Capital Following Strategic Update

Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment

Jord BioScience Raises Series B Funding to Advance Agricultural Microbial Solutions

Axol Bioscience Secures $2.8M to Expand iPSC Disease Model Platform and US Operations

Page 1 of 368